Ayurcann Holdings Corp. (AYUR.CN)
CAD 0.03
(-16.67%)
CAD 0.03
(-16.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 69.97 Thousand CAD | 108.85% |
| 2022 | -791.06 Thousand CAD | 20.79% |
| 2021 | -998.73 Thousand CAD | -299.53% |
| 2020 | -249.97 Thousand CAD | 60.74% |
| 2019 | -636.75 Thousand CAD | 53.08% |
| 2018 | -1.35 Million CAD | 14.98% |
| 2017 | -1.59 Million CAD | -36.41% |
| 2016 | -1.17 Million CAD | 14.77% |
| 2015 | -1.37 Million CAD | 12.06% |
| 2014 | -1.56 Million CAD | 12.36% |
| 2013 | -1.78 Million CAD | 5.44% |
| 2012 | -1.88 Million CAD | -385.83% |
| 2011 | -387.74 Thousand CAD | -424.29% |
| 2010 | -73.95 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -946.39 Thousand CAD | -19.64% |
| 2023 Q3 | -3.2 Million CAD | -42.87% |
| 2023 Q2 | -2.24 Million CAD | -136.84% |
| 2023 Q4 | 69.97 Thousand CAD | 102.19% |
| 2022 FY | -791.06 Thousand CAD | 20.79% |
| 2022 Q3 | -1.2 Million CAD | -41.01% |
| 2022 Q4 | -791.06 Thousand CAD | 34.56% |
| 2022 Q2 | -857.19 Thousand CAD | -23.89% |
| 2022 Q1 | -691.87 Thousand CAD | 30.72% |
| 2021 Q3 | -850.63 Thousand CAD | 42.12% |
| 2021 Q1 | -529.68 Thousand CAD | -111.9% |
| 2021 FY | -998.73 Thousand CAD | -299.53% |
| 2021 Q2 | -1.46 Million CAD | -177.45% |
| 2021 Q4 | -998.73 Thousand CAD | -17.41% |
| 2020 Q1 | -1.12 Million CAD | -63.99% |
| 2020 FY | -249.97 Thousand CAD | 60.74% |
| 2020 Q4 | -249.97 Thousand CAD | 52.52% |
| 2020 Q3 | -526.52 Thousand CAD | 50.3% |
| 2020 Q2 | -1.05 Million CAD | 5.5% |
| 2019 Q2 | -1.27 Million CAD | 5.77% |
| 2019 Q3 | -1.22 Million CAD | 4.29% |
| 2019 FY | -636.75 Thousand CAD | 53.08% |
| 2019 Q4 | -683.63 Thousand CAD | 44.14% |
| 2019 Q1 | -1.35 Million CAD | 2.83% |
| 2018 Q3 | -1.44 Million CAD | 2.83% |
| 2018 FY | -1.35 Million CAD | 14.98% |
| 2018 Q4 | -1.39 Million CAD | 3.63% |
| 2018 Q2 | -1.49 Million CAD | 6.57% |
| 2018 Q1 | -1.59 Million CAD | 5.55% |
| 2017 Q3 | -1.73 Million CAD | -57.79% |
| 2017 Q2 | -1.1 Million CAD | 5.9% |
| 2017 Q1 | -1.17 Million CAD | 3.36% |
| 2017 FY | -1.59 Million CAD | -36.41% |
| 2017 Q4 | -1.68 Million CAD | 2.73% |
| 2016 Q2 | -1.32 Million CAD | 3.77% |
| 2016 Q1 | -1.37 Million CAD | 2.76% |
| 2016 FY | -1.17 Million CAD | 14.77% |
| 2016 Q3 | -1.27 Million CAD | 3.59% |
| 2016 Q4 | -1.21 Million CAD | 4.94% |
| 2015 Q3 | -1.44 Million CAD | 3.88% |
| 2015 Q4 | -1.41 Million CAD | 2.25% |
| 2015 Q2 | -1.5 Million CAD | 3.75% |
| 2015 Q1 | -1.56 Million CAD | 2.2% |
| 2015 FY | -1.37 Million CAD | 12.06% |
| 2014 FY | -1.56 Million CAD | 12.36% |
| 2014 Q4 | -1.59 Million CAD | 3.89% |
| 2014 Q3 | -1.66 Million CAD | 3.27% |
| 2014 Q2 | -1.71 Million CAD | 3.6% |
| 2014 Q1 | -1.78 Million CAD | -16.24% |
| 2013 Q4 | -1.53 Million CAD | 5.05% |
| 2013 FY | -1.78 Million CAD | 5.44% |
| 2013 Q2 | -1.71 Million CAD | 8.8% |
| 2013 Q3 | -1.61 Million CAD | 6.04% |
| 2013 Q1 | -1.88 Million CAD | 11.24% |
| 2012 FY | -1.88 Million CAD | -385.83% |
| 2012 Q1 | -3.18 Million CAD | 42.83% |
| 2012 Q2 | -2.75 Million CAD | 13.54% |
| 2012 Q3 | -2.36 Million CAD | 14.09% |
| 2012 Q4 | -2.12 Million CAD | 10.35% |
| 2011 FY | -387.74 Thousand CAD | -424.29% |
| 2011 Q2 | -387.74 Thousand CAD | 1.87% |
| 2011 Q1 | -395.11 Thousand CAD | 3.52% |
| 2011 Q4 | -5.57 Million CAD | 15.67% |
| 2011 Q3 | -6.61 Million CAD | -1605.08% |
| 2010 Q3 | -292.88 Thousand CAD | 0.0% |
| 2010 FY | -73.95 Thousand CAD | 0.0% |
| 2010 Q4 | -409.54 Thousand CAD | -39.83% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | 91.529% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 108.689% |
| The BC Bud Corporation | 225.15 Thousand CAD | 68.919% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 98.455% |
| CordovaCann Corp. | 6.13 Million CAD | 98.859% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 98.488% |
| Captor Capital Corp. | -5.41 Million CAD | 101.293% |
| City View Green Holdings Inc. | 1.49 Million CAD | 95.329% |
| 1CM Inc. | 3.31 Million CAD | 97.889% |
| Global Hemp Group Inc. | 3.55 Million CAD | 98.03% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 99.517% |
| IM Cannabis Corp. | 11.96 Million CAD | 99.415% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | 63.619% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 97.171% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 101.183% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 115.58% |
| Ovation Science Inc. | 143.76 Thousand CAD | 51.324% |
| Pharmadrug Inc. | 1.2 Million CAD | 94.201% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | 62.429% |
| RAMM Pharma Corp. | -4.71 Million CAD | 101.485% |
| RIV Capital Inc. | -101.38 Million CAD | 100.069% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 108.771% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 99.973% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 99.664% |
| 1933 Industries Inc. | 16.47 Million CAD | 99.575% |
| Red Light Holland Corp. | -13.56 Million CAD | 100.516% |
| Top Strike Resources Corp. | 13.24 Million CAD | 99.472% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 168.327% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 96.825% |